Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,175 trials

NCT07269379
Recruiting
Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients
Not applicable · France · 2 sites
Registry update: 8 Dec 2025
NCT06769126
Recruiting
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Phase 2 · United States · 148 sites
Registry update: 30 Mar 2026
NCT06831526
Recruiting
Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
Early phase 1 · United States · 1 site
Registry update: 29 May 2026
NCT06931769
Recruiting
TAO-Towards Optimal (Neo)Adjuvant Systemic Therapy of Stage III Triple-negative Breast Cancer
Not applicable · Netherlands · 9 sites
Registry update: 7 Oct 2026
NCT07351734
Recruiting
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Trial of JKN2403 in COPD
Phase 2 · China · 1 site
Registry update: 20 Jan 2026
NCT07206225
Recruiting
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Phase 1 · Spain, France, United Kingdom, Israel, South Korea, United States · 71 sites
Registry update: 5 Nov 2026
NCT07097298
Recruiting
Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers
Not applicable · Switzerland · 1 site
Registry update: 1 Dec 2025
NCT05293080
Recruiting
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
Phase 3 · Germany, Spain, Netherlands · 41 sites
Registry update: 18 May 2026
NCT07219589
Recruiting
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
Phase 1 · United States · 1 site
Registry update: 4 May 2026
NCT07218276
Recruiting
Passive Robots for Stroke Rehabilitation: A Feasibility Study
Not applicable · United States · 1 site
Registry update: 10 Nov 2025
NCT07202247
Recruiting
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
Phase 2 · United States · 1 site
Registry update: 17 Aug 2026
NCT07586384
Recruiting
Single-port Versus Conventional Laparoscopic Surgery for Radical Proximal Gastric Cancer: A Randomized Controlled Trial
Not applicable · China · 1 site
Registry update: 14 May 2026
NCT07399821
Recruiting
An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma
Phase 1/2 · Netherlands · 1 site
Registry update: 10 Feb 2026
Conflicting statuses (not updated in the registry for 9 months)
NCT07268508
Recruiting
Impact of a Pro-diversity Gut Microbiota Diet After a Bariatric Surgery on Gut Microbiota, Eating Behaviour and Sensory Function
Not applicable · France · 3 sites
Registry update: 3 Apr 2026
NCT06984185
Recruiting
Early Detection of Type 1 Diabetes
Not applicable · France · 1 site
Registry update: 3 Sept 2026
2024-514879-17-00
Recruiting
The IPa-Gastric trial: Comparing Intraperitoneal Paclitaxel and Systemic Therapy versus Systemic Therapy alone in Gastric Cancer Patients with Peritoneal Metastasis
Phase 3 · Italy, Netherlands, Norway, Sweden · 9 sites
Registry update: 7 Sept 2026
NCT07100080
Recruiting
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Phase 2/3 · Argentina, Belgium, Canada, Switzerland, Chile, China, Colombia, Germany, Spain, France, United Kingdom, Greece, India, Italy, Japan, South Korea, Mexico, Netherlands, Norway, Poland, Romania, Singapore, Thailand, Taiwan, United States · 187 sites
Registry update: 9 Oct 2026
NCT07061977
Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Phase 3 · Puerto Rico, United States · 347 sites
Registry update: 9 Nov 2026
NCT07120698
Recruiting
Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)
Phase 2 · China · 2 sites
Registry update: 5 Jan 2026
2025-521315-39-00
Recruiting
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial-1)
Phase 1 · Belgium, Germany, Spain, Netherlands, Poland · 9 sites
Registry update: 6 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.